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I. Purpose 
Pneumonia is a major cause of hospitalization and mortality, especially in older 
adults. Along with the rapid growth of aging population, the importance of clinical 
practice for pneumonia and public health concerns have been increasing. 
Pneumonia is classified as community-acquired pneumonia (CAP), or hospital-
acquired pneumonia (HAP), depending on whether the infection developed while the 
patient is in an outpatient setting or in an inpatient setting. The distinction between CAP 
and HAP and understanding the etiologies on each pneumonia are critical for the clinical 
management on patients with pneumonia and the selection of appropriate antibiotic 
agents. In patients with HAP, the combination of resistant, difficult-to-treat organisms, 
along with the underlying disease conditions that accompany HAP, lead to a worse 
prognosis. The mortality rate associated with HAP was significantly higher than that for 
CAP. Ventilator-associated pneumonia (VAP) is defined as pneumonia developing in 
patients who have been on mechanical ventilation for ˃ 48 hours, and is a leading case of 
mortality in critically ill patients.  
Aspiration pneumonia (AsP) is classified by the cause of pneumonia and 
involves CAP, HAP, and VAP. A multicenter study in Japan indicated that approximately 
87% of HAP can be diagnosed as AsP. AsP increases with age and related to the high 
mortality and morbidity. However, the lack of the universal definition of AsP leads to the 
complication of clinical researches for elucidating the pathophysiology of AsP. Thus, 
HAP, VAP and AsP are important hospitalized infections that relate to severity and 
mortality.  
The purposes of the present study were; to elucidate the risk factors for AsP; to 
evaluate the influence of pneumonia on patients with dementia; and to evaluate the 
effective antibiotics treatment strategies for patients with HAP, VAP and AsP. Findings 
from this study would be important implications for present and future clinical 
managements on patients with hospitalized pneumonia for reducing disease severity and 
mortality. 
 
II. Materials and methods 
In order to achieve the goal of present study, six sub-studies in three main themes 
were conducted. The materials and methods were as follow. 
【Theme 1】 Risk factors on incidence of AsP  
Study 1: Definition, diagnosis and risk factors on AsP – A systematic review 
The studies published from 1949 to June 2015 were systematically reviewed. Among 
the eligible studies, the diagnostic or definition of AsP, common references that cited 
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as the definition of AsP, and risk disease and factors of AsP were assessed.  
Study 2: Risk factors for AsP in older adults in nursing and geriatric facilities in Japan 
The study subjects were 9930 patients in nursing and geriatric healthcare facilities in 
Japan (median age, 86 years; 76% female). The subjects were divided into two groups 
if they had an episode of AsP in the previous 3 months. Data on demographics, 
clinical status, activities of daily living, and major illness were compared between 
subjects with- and without-AsP. Factors relating to incidence of AsP were estimated 
using logistic regression model.  
【Theme 2】Effects of pneumonia on patients with dementia 
Study 3: Factors relating to pneumonia-caused death in older adults with autopsy 
confirmed dementia. 
The study subjects were 204 patients who were admitted, were underwent a post-
mortem examination, and were neuropathologically diagnosed with dementia 
between 2005 and 2015 in a hospital, Toyohashi, Japan. The risk factors for 
pneumonia-caused death were examined both as underlying and immediate causes of 
death using logistic regression models. 
Study 4: Pneumonia-caused hospital admission in patients with dementia in terminal 
stage 
The study subjects were selected from the study 3 and 158 patients who became 
hospitalized and then died, and who underwent post-mortem autopsy and diagnosed 
Alzheimer’s disease, dementia with Lewy bodies, and vascular dementia were 
included. The patients were divided into three groups based on the cause of hospital 
admission: CAP (pneumonia group; n=31), deterioration of dementia (dementia 
group; n=71), and other clinical causes (other-cause group; n=56). The survival-time 
after hospital admission was assessed according to the causes of hospital admission.  
【Theme 3】The antibiotics treatment strategies for patients with HAP, VAP and 
AsP.  
Study 5: Chronological change on bacteriology of AsP – A systematic review 
The data was selected from the systematic review in study 1. Of the 467 
references screened, 17 studies reported bacteriology of AsP and were included the 
analysis. The bacteriology of AsP was chronologically evaluated by the stratified 
terms of years; 1970-1989; 1990-2009; and 2010-2014. 
Study 6: Effect of de-escalation antibiotic therapy on HAP and VAP – A systematic 
review and meta-analysis 
A systematic review and meta-analysis was performed on studies examining 
de-escalation therapy in patients with HAP or VAP. A meta-analysis was conducted 
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using a random-effects model. The primary outcome was mortality, and the 
secondary outcomes were lengths of hospital stay, intensive care unit (ICU) stay, and 
antibiotic therapy. Stratified subgroup analyses were conducted among group of 
studies of VAP and those of HAP.   
 
III. Results  
【Theme 1】 Risk factors on incidence of AsP  
Study 1: Definition, diagnosis and risk factors on AsP – A systematic review 
Of the 467 references screened, 86 studies included in the final analysis. Among them, 
six studies examined on subjects with head and neck cancer and five studies 
examined on subjects with stroke. Although the criteria of subjects varied, age, 
dysphagia, suctioning, dehydration were major factors to the incidence of AsP as well 
as risk diseases including dementia and stroke. The incidence of AsP also varied from 
5% to 60% in the eligible studies.  
Study 2: Risk factors for AsP in older adults 
Two hundred and fifty-nine (2.6% of total) subjects were in a group of AsP. Risk 
factors for AsP by multiple logistic regression analysis of propensity-adjusted 
subjects (258 subjects each) were sputum suctioning (Odds ratio [OR], 3.276), 
deterioration of swallowing function in 3 months (OR, 3.584), dehydration (OR, 
8.019), and dementia (OR, 1.618).  
【Theme 2】Effects of pneumonia on patients with dementia 
Study 3: Factors relating to pneumonia-caused death in older adults with dementia. 
The factors related to pneumonia-caused death (underlying) were subtypes of 
dementia; Alzheimer’s disease (odds ratio [OR], 2.891); argyrophilic grain disease 
(OR, 3.148); and progressive supranuclear palsy (OR, 34.921), dysphagia (OR, 
2.045), diabetes mellitus (OR, 3.084) and conversely related with heart failure (OR, 
0.149). Factors relating to pneumonia-caused death (immediate) were incidence of 
pneumonia during hospitalizations (OR, 32.579), gender-male (OR, 2.060), and 
conversely related with malignant neoplasm (OR, 0.220). 
Study 4: Pneumonia-caused hospital admission in patients with dementia in terminal 
stage 
The mean duration of hospitalization was 20 months in the pneumonia group, 25.1 
months in other-cause groups, and 56.6 months in the dementia group. 54.8% of 
patients in pneumonia group survived over one year after admission.  
【Theme 3】Antibiotics treatment strategies for patients with HAP, VAP and AsP.  
Study 5: Chronological change on bacteriology of AsP – A systematic review 
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Total 1437 bacteriology in 17 studies was included the analysis of the present study. 
Of all eligible, 42% were gram-negative aerobic, 35% were gram positive aerobic, 
11% of anaerobic and 8% were fungi. Although major bacteriology of AsP were 
anaerobic in the study in 1970 - 1989, those in recent years (2010-2014) were 
Candida sp (19.1%), Staphylococcus aureus (18.2%), and Klebsiella pneumoniae 
(12.7%).    
Study 6: Effect of de-escalation antibiotic therapy on HAP and VAP – A systematic 
review and meta-analysis 
Nineteen studies (4420 patients) were eligible. Among them, nine were observational 
studies that examined de-escalation vs. non-de-escalation therapies and others were 
studies examining guideline-oriented de-escalation therapy. In all eligible studies, de-
escalation antibiotic therapy reduced hospital mortality (risk ratio [RR], 0.81; 95% 
confidence interval [95% CI], 0.65–0.99). Among observational studies, de-
escalation therapy has also reduced the risk of hospital mortality (RR, 0.58; 95% CI, 
0.39–0.86). As the stratified analysis in observational studies, de-escalation therapy 
on studies on HAP showed a significant reduced mortality (RR, 0.24; 95%CI, 0.07-
0.85), while those on VAP tended to reduce mortality (RR, 0.69; 95%CI, 0.47-1.01).  
 
IV. Discussion  
The present study intended to elucidate the risk factor on incidence of AsP and 
the effect of antibiotics treatment strategy on HAP, VAP and AsP. The study revealed that 
factors relating to the incidence of AsP were sputum suctioning, deterioration of 
swallowing function in 3 months, dehydration, and dementia. HAP was the major factor 
for pneumonia-caused death on patients with dementia along with dysphagia, subtypes of 
dementia, gender-male and diabetes mellitus. Although anaerobic bacteria were the major 
pathogen for AsP in the 1970s, the bacteriology of AsP changed chronologically. In recent 
years, major bacteriology was fungi and drug-resistant bacteria, which might be 
influenced by the increasing number of aging patients. De-escalation antibiotics therapy 
was effective treatment strategies for reducing mortality, especially for severe HAP and 
VAP including AsP. 
AsP does not have a universal definition. However, in Japan, AsP is defined 
according to the Japanese Study Group on Aspiration pulmonary Disease definition as 
pneumonia in a patient with a predisposition to aspiration because of dysphagia or 
swallowing disorders. Patients with dysphagia are likely to have pneumonia at a rate of 
1.6 to 11.9 times greater than patients without dysphagia. Thus, dysphagia is the major 
risk factor of the AsP. The risk diseases relating to dysphagia such as dementia, stroke, 
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head and neck cancer were also the risks to AsP. The other risks were age-related 
condition in frail older adults, which partly explains why aging increases the risk of AsP. 
These factors can be included into the definition and diagnostic criteria of AsP. 
Anaerobic has not been common in the recent years; however, fungi and multi-
drug resistant pathogen appear to be common. Aging population as well as increased 
number of patients with bedridden may influenced those results. Although the reported 
bacteriology may not be the pathogen that caused AsP, the present study indicated that 
the selection of antibiotic therapy needs to consider the clinical and living conditions of 
patients. The use of broad-spectrum antimicrobials with subsequent de-escalation in 
patients with HAP, VAP, and HCAP was associated with a reduction in mortality, 
especially less severe pneumonia. Thus, the pneumonia severity and bacteriology may 
influence the effect of de-escalation antibiotic therapy on mortality. The underlying 
conditions of patients in the ICU may also impact the risk of mortality. 
 
V. Conclusion 
 Risk factors to AsP were dysphagia and age-related disorders and frail condition. 
Clinical management on patients with AsP requires the comprehensive consideration both 
of clinical and general backgrounds of patients. De-escalation antibiotic therapy may 
contribute to reduce mortality on patients with HAP, VAP and HCAP. 
 
